Financials

News Ideas Discussions Technicals Forecast

KNSA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Kiniksa Pharmaceuticals, Ltd.

Total assets of KNSA for Q2 24 is 542.43 M USD, 4.38% more than the previous Q1 24. And total liabilities increased by 22.28% in Q2 24 to 107.33 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—